stockrow
Saturday 7 November 2026
Export ANVS’s income statement to Excel — free account
Annovis Bio, Inc.
ANVS Healthcare Biotechnology
- EPS
- −25.0%
- Free cash flow
- −329.2%
Quarter to June 2026, against a year earlier
0.82
0.15
+22.39%
Follow ANVS
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (703.68%) | (301.13%) | (220.61%) | (246.14%) |
+8 more TTM periods Free account |
|
| (227.74%) | (190.43%) | (164.85%) | (157.74%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(315.88%) | (1,185.13%) | (165.39%) | (184.94%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.16) | (0.95) | (1.25) | (1.27) | |
Free Cash Flow |
(43.34) | (26.53) | (25.62) | (24.98) | |
| Other line items | |||||
Cash ROIC |
(299.43%) | (152.97%) | (70.42%) | (87.82%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.88 | 0.65 | 0.89 | 1.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.16) | (0.95) | (1.25) | (1.27) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates